iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
33.53
-0.59 (-1.72%)
Sep 24, 2026, 4:00 PM EDT - Market closed
IBRN Holdings Information
IBRN is an equity ETF with a total of 83 individual holdings. The top holdings are Biogen stock at 4.66%, Edgewise Therapeutics at 4.30%, argenx SE at 4.15%, Alkermes at 4.13%, and ACADIA Pharmaceuticals at 4.10%.
Total Holdings
83
Top 10 Percentage
41.03%
Asset Class
Equity
ETF Category
Health
Assets
7.05M
PE Ratio
16.48
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BIIB | Biogen Inc. | 4.66% |
| 2 | EWTX | Edgewise Therapeutics, Inc. | 4.30% |
| 3 | ARGX | argenx SE | 4.15% |
| 4 | ALKS | Alkermes plc | 4.13% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 4.10% |
| 6 | SRRK | Scholar Rock Holding Corporation | 4.07% |
| 7 | PTCT | PTC Therapeutics, Inc. | 4.06% |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 4.05% |
| 9 | DNTH | Dianthus Therapeutics, Inc. | 3.90% |
| 10 | PRAX | Praxis Precision Medicines, Inc. | 3.62% |
| 11 | SUPN | Supernus Pharmaceuticals, Inc. | 3.37% |
| 12 | AXGN | Axogen, Inc. | 3.25% |
| 13 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 3.12% |
| 14 | DYN | Dyne Therapeutics, Inc. | 3.02% |
| 15 | XENE | Xenon Pharmaceuticals Inc. | 2.76% |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 2.73% |
| 17 | HLUNB.CO | H. LUNDBECK CLASS B | 2.56% |
| 18 | BHVN | Biohaven Ltd. | 2.50% |
| 19 | ASX: NEU | Neuren Pharmaceuticals Limited | 2.28% |
| 20 | STO: BIOA.B | BioArctic AB (publ) | 1.98% |
| 21 | TSHA | Taysha Gene Therapies, Inc. | 1.85% |
| 22 | TYO: 4588 | Oncolys BioPharma Inc. | 1.63% |
| 23 | IART | Integra LifeSciences Holdings Corporation | 1.48% |
| 24 | SWX: IDIA | Idorsia Ltd | 1.48% |
| 25 | LBRX | LB Pharmaceuticals Inc | 1.48% |
As of Sep 23, 2026